What is Enwei Pharmaceutical Co Price-to-Operating-Cash-Flow?
As of today (2024-05-27), Enwei Pharmaceutical Co's share price is ¥27.25.
Enwei Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.86. Hence, Enwei Pharmaceutical Co's Price-to-Operating-Cash-Flow Ratio for today is 31.54.
The historical rank and industry rank for Enwei Pharmaceutical Co's Price-to-Operating-Cash-Flow or its related term are showing as below:
SZSE:301331'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 26.46 Med: 36.35 Max: 48.69
Current: 31.53
During the past 7 years, Enwei Pharmaceutical Co's highest Price-to-Operating-Cash-Flow Ratio was 48.69. The lowest was 26.46. And the median was 36.35.
Enwei Pharmaceutical Co's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was ¥0.06.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.86.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Enwei Pharmaceutical Co was 8.00% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -9.00% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -5.20% per year.
During the past 7 years, Enwei Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 13.60% per year. The lowest was -21.70% per year. And the median was -12.30% per year.
Enwei Pharmaceutical Co Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Enwei Pharmaceutical Co's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enwei Pharmaceutical Co Price-to-Operating-Cash-Flow Chart
|
Enwei Pharmaceutical Co Annual Data
|
|
Trend |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
- |
- |
- |
36.35 |
34.63 |
|
Enwei Pharmaceutical Co Quarterly Data
|
|
Dec17 |
Dec18 |
Dec19 |
Mar20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
33.32 |
40.60 |
43.89 |
34.63 |
27.79 |
Competitive Comparison of Enwei Pharmaceutical Co's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Enwei Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Enwei Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Enwei Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Enwei Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.
Enwei Pharmaceutical Co Price-to-Operating-Cash-Flow Calculation
Enwei Pharmaceutical Co's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 27.25 | / | 0.864 |
| = | 31.54 |
Enwei Pharmaceutical Co's Share Price of today is ¥27.25.
Enwei Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.86.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Enwei Pharmaceutical Co (SZSE:301331) Business Description
Traded in Other Exchanges
N/A
Address
Chuangye Avenue, Enwei Building, Economic Development Zone, Aba District, Tibet Autonomous Region, Changdu, CHN, 854000
Enwei Pharmaceutical Co Ltd is engaged in the research and development, production and sales of proprietary Chinese medicines and chemical medicines.
Enwei Pharmaceutical Co (SZSE:301331) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:301331 has been successfully added to your